Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
16:41
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

International Liver Cancer Association 14th Annual Conference

 

September 11-13, 2020 Virtual Conference
FAQs
   
Discussion forum - International Liver Cancer Association 20th Annual Conference
    Topic - Molecular Pathogenesis, Cell Biology and Translational Research

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Cold-Inducible Rna Binding Protein As A Vaccination Platform Against Hepatocellular Carcinoma  Marķa De Dios Lera 1      9/22/2020 1:28:00 PM  
Rac1 Inhibition As A New Therapeutic Target For Hcc  Juan Bayo 1      9/22/2020 1:28:00 PM  
Expression Of P62/Sqstm1 In Hepatocellular Carcinoma And Its Relation To Tumor Recurrence After Radiofrequency Thermal Ablation  Assem El-Shendidi 1      9/22/2020 1:28:00 PM  
Trem2 Defends The Liver Against Hepatocellular Carcinoma Through Multifactorial Protective Mechanisms  Ibone Labiano Ciriza 1      9/22/2020 1:28:00 PM  
Novel Strategies To Target Mitochondria In Bile Duct Cancers  Pietro Carotenuto 1      9/22/2020 1:28:00 PM  
Rsk2 Mutation-Driven Mapk Activation Sensitizes Sorafenib Treatment And DrivesCholesterol Metabolism In Hepatocellular Carcinoma  Irene Ng 1      9/22/2020 1:28:00 PM  
Animal Models Of Liquid Biopsy In Hepatocellular Carcinoma Reveal Clone-Dependent Release Of Circulating Tumor Dna  Ismail Labgaa 1      9/22/2020 1:28:00 PM  
Identification Of Neoantigen-Reactive Tumor-Infiltrating T Cell In Hepatocellular Carcinoma.  Enric Vercher Herraez 1      9/22/2020 1:28:00 PM  
Activated Peripheral Blood Lymphocytes Of Hepatocellular Carcinoma Patients (Hcc) Are Associated With Increased Risk Of Early Dermatologic Adverse Effects During Sorafenib Treatment  Josep Corominas 1      9/22/2020 1:28:00 PM  
Characterization Of Chromatin Accessibility In Hepatocellular Carcinoma Cells Using Single Cell Atac Sequencing  Amanda Craig 1      9/22/2020 1:28:00 PM  
Prueba  Daniel Armando 1      9/22/2020 1:28:00 PM  
Testis-Associated Lncrnas As Therapeutic Targets Against Hepatocellular Carcinoma  Juan Unfried 1      9/22/2020 1:28:00 PM  
Silencing Of Hepatic Discoidin Domain Receptor 1 Reduces Murine Liver Metastasis By Colon Carcinoma. Role Of Sinusoidal Discoidin Domain Receptor 1 In Liver Metastasis.  Irene Pecora 1      9/22/2020 1:28:00 PM  
Silencing Of Ddr1 Expression In Murine C26 Colon Carcinoma Reduces Experimental Liver Metastasis. Blockage Of Ddr1 Phosphorylation In Sinusoidal Cells Diminish Prometastatic Features Of C26 Cells.  Irene Pecora 1      9/22/2020 1:28:00 PM  
Immune-remodeling effects of lenvatinib plus anti-PD1 in a murine model of hepatocellular carcinoma  Laura Torrens 1      9/22/2020 1:28:00 PM  
Dual Targeting Of Tumor Associated Macrophages And Immunosuppressive Granulocytic Myeloid-Derived Suppressor Cells Augments Pd-1 Blockade In Cholangiocarcinoma  Jihye Lim 1      9/22/2020 1:28:00 PM  
Immune Profiling Of Combined hepatocellular-Cholangiocarcinoma  Julien Calderaro 1      9/22/2020 1:28:00 PM  
Defining The Temporal Evolution Of The Gut Microbiome And Associated Intrahepatic Immune Response In The Mdr2-/- Model Of Hepatocellular Carcinoma  Jason Behary 1      9/22/2020 1:28:00 PM  
Identification Of Neoantigens As Potential Vaccines In Hepatocellular Carcinoma.  Marķa De Dios Lera 1      9/22/2020 1:28:00 PM  
Modeling Hepatocellular Carcinoma In The Minipig  Barbara Tschida 1      9/22/2020 1:28:00 PM  
Cyclooxygenase 2 (Cox-2) Inhibition Counteracts Icam-1 Modulation Of Liver Microenvironment During Metastatic Development  Alba Alonso 1      9/22/2020 1:28:00 PM  
Implications of NOTCH3 Expression and Signaling for Cholangiocarcinogenesis  Sarah Fritzsche 1      9/22/2020 1:28:00 PM  
       




Most viewed poster for this congress
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre: 

Poster most viewed in this topic
Poster: 91
Visits: 64
Title: Dual Targeting Of Tumor Associated Macrophages And Immunosuppressive Granulocytic Myeloid-Derived Suppressor Cells Augments Pd-1 Blockade In Cholangiocarcinoma
Authors: Emilien Loeuillard , Emilien Loeuillard
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert